Connect with us

Hi, what are you looking for?

Uncategorized

How Trump’s Sanctions Are Making Life Hell for Iranians

TEHRAN — The rain poured so hard on Nasser Khosro Street that even the drug dealers sought shelter. They stepped across large puddles as motorcycles with plastic windshields whizzed by. But these drug dealers weren’t selling heroin or cocaine. They were offering diabetes medication and injectable chemotherapy drugs. U.S. sanctions have wreacked economic havoc on…

How Trump’s Sanctions Are Making Life Hell for Iranians

TEHRAN — The rain poured so hard on Nasser Khosro Street that even the drug dealers sought shelter. They stepped across large puddles as motorcycles with plastic windshields whizzed by. But these drug dealers weren’t selling heroin or cocaine. They were offering diabetes medication and injectable chemotherapy drugs.

U.S. sanctions have wreacked economic havoc on Iran for years, and President Donald Trump intensified them after Iran attacked an Iraqi base housing American soldiers in retaliation for Washington’s killing of Iranian military leader Qassem Soleimani in early January. The local currency has lost two-thirds of its value over the past two years. That means imported medicine to hospitals and pharmacies has become prohibitively expensive or not available at all. So Iranians turn to the black marketers of Nasser Khosro Street.

The street dealers assure customers that theirs is the highest-quality medicine made in Europe. It is smuggled into Iran through Turkey and northern Iraq, they say.

“You can check the bar code on the box to see its authenticity,” one dealer said with the bravado of a merchant selling overpriced carpets. He pulls out a cell phone, calls his supplier, and announces the price for the chemotherapy drug MabThera.

In 2013, during the Obama administration’s imposition of harsh sanctions on Iran prior to signing the nuclear accord, black-market MabThera cost $70 per 100 ml dose. Now the dealer offered it for $140. Used to treat lymphocytic leukemia, it normally requires eight doses over a period of weeks. That’s unaffordable to all but the very rich in a country where the average wage is $1,245 a month.

READ: ‘It’s a punch in the face to Trump’: Why Soleimani’s killing could mean hard-line victories in Iran’s elections.

And the dealer warns that the MabThera might not be available right away.

“I couldn’t even get cough syrup for my baby,” he said. “It’s getting very difficult for me, and I sell the drugs.”

Advertisement. Scroll to continue reading.

SInce 2018 the Trump administration has steadily squeezed the Iranian economy with the stated goal of forcing Iran’s leaders to negotiate a new nuclear agreement. Sanctions aren’t intended to harm ordinary people, according to Trump officials.

“A big part of our Iran strategy from the very beginning is standing with the Iranian people instead of standing with the regime,” said Brian Hook, the U.S. special representative for Iran.

The Trump administration has stopped most Iranian oil sales and cut the country off from the international banking system. So U.S. sanctions hurt ordinary Iranians, not just the elite, according to Paul Pillar, a former CIA officer and now an Iran expert at Georgetown University’s Center for Security Studies.

“Secretary of State Mike Pompeo and others in the administration favor regime change,” he said in a phone interview. “Therefore they do not shed any tears over hardships facing ordinary Iranians.”

Washington officials know sanctions impact ordinary Iranians because they “deter all forms of trade — humanitarian and non-humanitarian alike.”

The unilateral U.S. sanctions — together with Iranian mismanagement and corruption — have created massive economic problems. Inflation hit 26% in January and the economy shrank by 7.1% last year. The devaluation of the currency drives up the cost of anything purchased abroad, from car parts to industrial chemicals.

READ: The Middle East was already a powder keg of misinformation. Trump just lit the match.

At first Professor Reza Roosta Azad, the former chancellor of Sharif University of Technology, might seem a strange candidate to be shopping on Nasser Khosro Street. He and some fellow professors have set up a profitable private lab where they’re producing the enzymes that go into laundry detergents. He’s looking for chemical reagents to produce those enzymes.

Once he locates a source on Nasser Khosro Street, he gets a sample chemical and then uses sophisticated testing equipment back at his lab to check purity.

Advertisement. Scroll to continue reading.

He pays twice the pre-sanctions price for the reagents but can sell the enzymes for 10 times more. “For entrepreneurs, it’s very good,” he said.

U.S. sanctions foster illegality, he explained, because the Iranian government knows people need the black market to survive. “The government looks the other way,” he said. “There’s no difference between legal and illegal at the moment because of the sanctions.”

There’s also a financial incentive, he added. Neither black marketeers nor grey-market business people pay taxes or face government inspection. If the companies do manage to buy or sell products abroad, they engage in what international banks would otherwise consider money laundering by hiding the origin of their wire transfers.

Page 1 of 2
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © 2020 Tribune Media LLC